Cetera Advisor Networks’s AbbVie ABBV Stock Holding History

Cetera Advisor Networks’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$51.5M	Sell	282,993 -4,568	-2%	-$787K	0.26%	80
2023 Q4	$44.6M	Sell	287,561 -344	-0.1%	-$50.2K	0.25%	86
2023 Q3	$42.9M	Buy	287,905 +3,904	+1%	+$573K	0.27%	78
2023 Q2	$38.3M	Sell	284,001 -1,236	-0.4%	-$181K	0.27%	78
2023 Q1	$45.5M	Buy	285,237 +10,031	+4%	+$1.53M	0.34%	58
2022 Q4	$44.5M	Buy	275,206 +45,765	+20%	+$7.02M	0.36%	51
2022 Q3	$30.8M	Buy	229,441 +31,024	+16%	+$4.45M	0.38%	45
2022 Q2	$30.4M	Buy	198,417 +10,007	+5%	+$1.53M	0.39%	42
2022 Q1	$30.5M	Buy	188,410 +6,807	+4%	+$989K	0.37%	47
2021 Q4	$24.6M	Buy	181,603 +5,969	+3%	+$705K	0.3%	61
2021 Q3	$18.9M	Buy	175,634 +12,588	+8%	+$1.44M	0.26%	78
2021 Q2	$18.4M	Buy	163,046 +81,353	+100%	+$9.16M	0.26%	77
2021 Q1	$8.84M	Buy	81,693 +6,795	+9%	+$727K	0.19%	128
2020 Q4	$8.03M	Buy	74,898 +6,173	+9%	+$593K	0.19%	125
2020 Q3	$6.02M	Buy	68,725 +1,257	+2%	+$118K	0.16%	145
2020 Q2	$6.62M	Buy	67,468 +9,201	+16%	+$810K	0.18%	130
2020 Q1	$4.44M	Buy	58,267 +927	+2%	+$79K	0.15%	152
2019 Q4	$5.08M	Buy	57,340 +4,199	+8%	+$349K	0.14%	151
2019 Q3	$4.03M	Buy	53,141 +36	+0.1%	+$2.47K	0.12%	169
2019 Q2	$3.86M	Buy	53,105 +4,209	+9%	+$331K	0.12%	170
2019 Q1	$3.92M	Sell	48,896 -1,790	-4%	-$146K	0.13%	157
2018 Q4	$4.66M	Buy	50,686 +2,860	+6%	+$252K	0.18%	115
2018 Q3	$4.52M	Buy	47,826 +9,980	+26%	+$946K	0.16%	128
2018 Q2	$3.51M	Sell	37,846 -604	-2%	-$59K	0.18%	104
2018 Q1	$3.64M	Sell	38,450 -2,730	-7%	-$300K	0.16%	135
2017 Q4	$3.99M	Buy	41,180 +125	+0.3%	+$11.8K	0.17%	136
2017 Q3	$3.65M	Sell	41,055 -1,624	-4%	-$124K	0.17%	135
2017 Q2	$3.1M	Sell	42,679 -155	-0.4%	-$10.4K	0.15%	145
2017 Q1	$2.81M	Buy	42,834 +3,356	+9%	+$211K	0.13%	159
2016 Q4	$2.48M	Sell	39,478 -14,232	-26%	-$869K	0.13%	160
2016 Q3	$3.39M	Buy	53,710 +9,907	+23%	+$641K	0.13%	167
2016 Q2	$2.7M	Sell	43,803 -6,136	-12%	-$374K	0.16%	144
2016 Q1	$2.86M	Buy	49,939 +1,998	+4%	+$111K	0.18%	127
2015 Q4	$2.84M	Buy	47,941 +1,732	+4%	+$99.8K	0.18%	131
2015 Q3	$2.51M	Buy	46,209 +2,427	+6%	+$158K	0.17%	135
2015 Q2	$2.57M	Hold	43,782	–	–	0.16%	136
2015 Q1	$2.57M	Buy	43,782 +7,969	+22%	+$481K	0.17%	136
2014 Q4	$2.36M	Sell	35,813 -19,267	-35%	-$1.21M	0.17%	138
2014 Q3	$3.2M	Buy	55,080 +591	+1%	+$32.8K	0.22%	96
2014 Q2	$3.08M	Sell	54,489 -996	-2%	-$52.3K	0.2%	110
2014 Q1	$2.84M	Buy	55,485 +2,765	+5%	+$140K	0.2%	114
2013 Q4	$2.79M	Sell	52,720 -20,473	-28%	-$1.01M	0.21%	103
2013 Q3	$3.25M	Sell	73,193 -995	-1%	-$44.1K	0.28%	77
2013 Q2	$3.05M	Buy	+74,188	New	+$3.24M	0.3%	71

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cetera Advisor Networks's ABBV Position: Q1 2024 in Review

Cetera Advisor Networks reduced its AbbVie (ABBV) stake by 1.6% in Q1 2024, selling an estimated $787K and leaving 282,993 shares worth $51.5M. The position accounts for 0.26% of the portfolio, ranked #80.

Cetera Advisor Networks first reported a position in ABBV in Q2 2013 and has held it in 44 quarters since. 3,380 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

Cetera Advisor Networks held 282,993 shares of AbbVie worth $51.5M as of Q1 2024.
Cetera Advisor Networks sold 4,568 AbbVie shares in Q1 2024, an estimated $787K.
AbbVie made up 0.26% of Cetera Advisor Networks's portfolio in Q1 2024, its #80 holding.
Cetera Advisor Networks first reported a position in AbbVie in Q2 2013 and has held it in 44 quarters since.
3,380 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.